NYMC Faculty Publications
CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung Cancer
Author Type(s)
Faculty
DOI
10.1158/0008-5472.CAN-21-4029
Journal Title
Cancer Research
First Page
4016
Last Page
4030
Document Type
Article
Publication Date
11-2-2022
Department
Pharmacology
Abstract
The identification of a role for CYP4F2-dependent metabolism in driving immune evasion in non-small cell lung cancer reveals a strategy to improve the efficacy of immunotherapy by inhibiting CYP4F2. See related article by Van Ginderachter, p. 3882.
Recommended Citation
Chen, X., Liu, Y., Wang, Y., Wang, C., Chen, X., Xiong, Y., Liu, L., Yuan, X., Tang, H., Shu, C., Zhang, J., Guo, A. M., Chen, H., & Yang, J. (2022). CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung Cancer. Cancer Research, 82 (21), 4016-4030. https://doi.org/10.1158/0008-5472.CAN-21-4029